Welcome to LookChem.com Sign In|Join Free
  • or
3-(Boc-aMino)-3-(4-chlorophenyl)-1-propanol is a chemical compound with the molecular formula C13H19NO3Cl. It is a derivative of 3-(4-chlorophenyl)-1-propanol that contains a Boc (tert-butyloxycarbonyl) protecting group on the amino group. 3-(Boc-aMino)-3-(4-chlorophenyl)-1-propanol is characterized by its ability to be selectively manipulated due to the presence of the Boc protecting group, making it a valuable building block in the synthesis of complex organic molecules. The chlorophenyl group also provides a site for further functionalization, contributing to the versatility of 3-(Boc-aMino)-3-(4-chlorophenyl)-1-propanol for use in diverse chemical reactions.

886493-66-9

Post Buying Request

886493-66-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

886493-66-9 Usage

Uses

Used in Pharmaceutical Industry:
3-(Boc-aMino)-3-(4-chlorophenyl)-1-propanol is used as an intermediate in the production of pharmaceuticals for its role in the synthesis of biologically active compounds. The Boc protecting group allows chemists to selectively modify the amino functionality, which is crucial for the development of new drugs with specific therapeutic properties.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(Boc-aMino)-3-(4-chlorophenyl)-1-propanol serves as a key intermediate. Its structural features, including the Boc protecting group and the chlorophenyl moiety, make it a versatile component in creating a wide range of complex organic molecules for various applications, including but not limited to materials science, agrochemicals, and specialty chemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 886493-66-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,4,9 and 3 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 886493-66:
(8*8)+(7*8)+(6*6)+(5*4)+(4*9)+(3*3)+(2*6)+(1*6)=239
239 % 10 = 9
So 886493-66-9 is a valid CAS Registry Number.

886493-66-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[1-(4-chlorophenyl)-3-hydroxypropyl]carbamate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:886493-66-9 SDS

886493-66-9Relevant academic research and scientific papers

Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H- pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases

Addie, Matt,Ballard, Peter,Buttar, David,Crafter, Claire,Currie, Gordon,Davies, Barry R.,Debreczeni, Judit,Dry, Hannah,Dudley, Philippa,Greenwood, Ryan,Johnson, Paul D.,Kettle, Jason G.,Lane, Clare,Lamont, Gillian,Leach, Andrew,Luke, Richard W. A.,Morris, Jeff,Ogilvie, Donald,Page, Ken,Pass, Martin,Pearson, Stuart,Ruston, Linette

, p. 2059 - 2073 (2013/05/08)

Wide-ranging exploration of analogues of an ATP-competitive pyrrolopyrimidine inhibitor of Akt led to the discovery of clinical candidate AZD5363, which showed increased potency, reduced hERG affinity, and higher selectivity against the closely related AGC kinase ROCK. This compound demonstrated good preclinical drug metabolism and pharmacokinetics (DMPK) properties and, after oral dosing, showed pharmacodynamic knockdown of phosphorylation of Akt and downstream biomarkers in vivo, and inhibition of tumor growth in a breast cancer xenograft model.

PYRROLO [2,3-D] PYRIMIDIN DERIVATIVES AS PROTEIN KINASE B INHIBITORS

-

Page/Page column 103, (2009/05/30)

The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 886493-66-9